Impact of Baseline Clinical Variables on SGLT2i’s Antiproteinuric Effect in Diabetic Kidney Disease

Introduction: Proteinuria is a major risk factor for the progression of chronic kidney disease (CKD). Sodium-glucose cotransporter 2 inhibitors (SGLT2i) demonstrated a nephroprotective and antiproteinuric effect in people with type 2 diabetes (T2DM) and proteinuric CKD. We conducted a retrospective...

Descripción completa

Detalles Bibliográficos
Autores principales: Capelli, Irene, Ribichini, Danilo, Provenzano, Michele, Vetrano, Daniele, Aiello, Valeria, Cianciolo, Giuseppe, Vicennati, Valentina, Tomassetti, Alessandro, Moschione, Ginevra, Berti, Sabrina, Pagotto, Uberto, La Manna, Gaetano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10143899/
https://www.ncbi.nlm.nih.gov/pubmed/37109590
http://dx.doi.org/10.3390/life13041061

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10143899/
https://www.ncbi.nlm.nih.gov/pubmed/37109590
http://dx.doi.org/10.3390/life13041061

Ejemplares similares